Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LY2109761 |
Trade Name | |
Synonyms | LY-2109761|LY 2109761 |
Drug Descriptions |
LY2109761 is a pan-TGFBR inhibitor, which prevents downstream signaling and may block proliferation and migration in cancer cells (PMID: 18413796, PMID: 32531714). |
DrugClasses | TGFBR inhibitor (pan) 2 |
CAS Registry Number | 700874-71-1 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LY2109761 | LY2109761 | 0 | 0 |
LY2109761 + Paclitaxel | LY2109761 Paclitaxel | 0 | 0 |